Frequent Links
lipid-risk-factors-research-articles.phpUnderpricingVancomycinGreenhouse Gasartificial-neural-network-latest-research-papersAnalytical ToxicologyProbioticsPeriodonticsEcosystem Psychosocial rehabilitationSpermatogonial Stem Cells Top Open Access Journalsepitope-mappingScholarly journals in Cell TherapyMultiple sclerosis treatmentcardiac pharmacology research articles
Morforex
| File:Morforex.svg | |
| Systematic (IUPAC) name | |
|---|---|
| 4-[2-[(α-Methylphenethyl)amino]ethyl]morpholine | |
| Clinical data | |
| Identifiers | |
| 41152-17-4 | |
| None | |
| PubChem | CID 3047774 |
| ChemSpider | 2310095 |
| Chemical data | |
| Formula | C15H24N2O |
| 248.364 g/mol | |
| |
| |
Morforex (INN; Bo 637), also referable to as N-morpholinoethylamphetamine, is an anorectic which was never marketed.[1][2]
It produces amphetamine as an active metabolite.[3]
See also
References
- ^ C.R. Ganellin; David J. Triggle (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 1377–. ISBN 978-0-412-46630-4.
- ^ World Health Organization (2000). International Nonproprietary Names (INN) for Pharmaceutical Substances. World Health Organization. ISBN 978-0-11-986227-0.
- ^ B.L. Goodwin (10 November 2004). Handbook of Biotransformations of Aromatic Compounds. CRC Press. pp. 13–. ISBN 978-0-203-64196-5.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lua error in package.lua at line 80: module 'Module:Buffer' not found.